However, if you have type 2 diabetes, you may qualify for GLP-1 medications approved for diabetes management (Ozempic, Mounjaro) regardless of BMI, and weight loss occurs as a secondary benefit
Murata M, Mihara M, Hasegawa K, Jeon B, Tsai C-H, Nishikawa N, Oeda T, Yokoyama M, Robieson WZ, Ryman D, Eaton S, Chatamra K, Benesh J
GLP-1 medication safety concerns in patients with breast cancer There is limited data on the safety of GLP-1 agonists in cancer patients, especially those who are undergoing treatment
In response to shortages and high out-of-pocket costs, they introduced compounded semaglutide
States We Serve How we reviewed this article: Harvard School of Public Health (2023)
El proceso es 100% por escrito y sin cita previa, simplemente rellenando un cuestionario de salud